Myoclonic dystonia.
Obeso JA, Rothwell JC, Lang AE, Marsden CD.
Neurology. 1983 Jul;33(7):825-30. doi: 10.1212/wnl.33.7.825.
Myoclonic dystonia.
Pueschel SM, Friedman JH, Shetty T.
Childs Nerv Syst. 1992 Mar;8(2):61-6. doi: 10.1007/BF00298440.
Myoclonus-dystonia syndrome.
Nardocci N.
Handb Clin Neurol. 2011;100:563-75. doi: 10.1016/B978-0-444-52014-2.00041-0.
[Myoclonic dystonia].
Cassim F.
Rev Neurol (Paris). 2003 Oct;159(10 Pt 1):892-9.
Myoclonic dystonia (DYT11) responsive to lacosamide: a case report.
Salari M, Asadi S, Etemadifar M, Rezaee M.
Acta Neurol Belg. 2022 Dec;122(6):1631-1632. doi: 10.1007/s13760-021-01756-5. Epub 2021 Jul 17.
Essential myoclonus and myoclonic dystonia.
Quinn NP.
Mov Disord. 1996 Mar;11(2):119-24. doi: 10.1002/mds.870110202.
Myoclonus.
Gerschlager W, Brown P.
Curr Opin Neurol. 2009 Aug;22(4):414-8. doi: 10.1097/WCO.0b013e32832d9d4f.
Correction to: Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
Dzinovic I, Serranová T, Prouteau C, Colin E, Ziegler A, Winkelmann J, Jech R, Zech M.
Neurogenetics. 2022 Jan;23(1):77. doi: 10.1007/s10048-021-00641-w.
Myoclonic Dystonia: A Common Phenomenology in the Pleomorphic Movements of Angelman Syndrome.
Carson RP, Riordan H, Short B, Davis T, Fang J, Giritharan A, Isaacs DA, Blackburn J, Aravamuthan B.
Mov Disord Clin Pract. 2025 May 2. doi: 10.1002/mdc3.70106. Online ahead of print.
Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
Dzinovic I, Serranová T, Prouteau C, Colin E, Ziegler A, Winkelmann J, Jech R, Zech M.
Neurogenetics. 2021 May;22(2):137-141. doi: 10.1007/s10048-021-00637-6. Epub 2021 Mar 6.
